The FDA is expected to authorize 2nd boosters for people 50 and up
(By Rob Stein and Jane Greenhalgh for NPR) Anyone 50 years and older could soon be eligible for a second
Read More
FDA
Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
(By Judith Graham for Kaiser Health News) If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might
Read MoreFDA approves 1st smartphone app that can deliver extra doses of insulin
(By Naomi Diaz for Becker’s Ho spital Review ) The FDA cleared the first app for iPhone and Android devices
Read MoreFDA wary of drugs developed in China
(By Erica Carbajal for Becker’s Hospital Review ) The FDA is concerned about the quality of studies evaluating cancer drugs
Read MoreFDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited
(By Matthew Herper for ST A T) The Food and Drug Administration on Thursday granted emergency authorization to Merck’s molnupiravir,
Read MoreNew antiviral drugs are coming for COVID. Here’s what you need to know
(By Pien Huang for NPR) An FDA advisory committee is meeting Tuesday to consider whether to recommend a new antiviral
Read MoreFDA recalling 2 million Ellume at-home COVID-19 test kits because of false positives
(By Dave Mistich for NPR) The U.S. Food and Drug Administration has announced a recall of about 2 million at-home
Read MoreQ&A: Bioethicist Leigh Turner on the worrisome boom in unregulated stem cell clinics
(By Megan Molteni for ST A T) In 2016, the Food and Drug Administration put the emerging stem cell cottage
Read More2 blood pressure drugs recalled because of concern about cancer-causing ingredient
(By Rachel Treisman for NPR) Two types of blood pressure medication made by the company Lupin Pharmaceuticals are being recalled
Read MoreFDA authorizes booster shots of Moderna, Johnson & Johnson Covid-19 vaccines
(By Helen Branswell and Matthew Herper for ST A T) Many Americans who have been vaccinated against Covid-19 will soon
Read More